Selected research
Market Structure
Global Biodegradable Type Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biodegradable Type Embolic Microspheres market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Biodegradable Type Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biodegradable Type Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biodegradable Type Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biodegradable Type Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biodegradable Type Embolic Microspheres include ABK Biomedical, Angio Dynamics, Biocompatibles, Biosphere Medical, BTG Corporate, CeloNova BioSciences, Merit Medical Systems, Mermaid Medical and Next Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Biodegradable Type Embolic Microspheres output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Biodegradable Type Embolic Microspheres by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Biodegradable Type Embolic Microspheres market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biodegradable Type Embolic Microspheres and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biodegradable Type Embolic Microspheres sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biodegradable Type Embolic Microspheres market size, projected growth trends, production technologies, key applications, and end-use industries.
Biodegradable Type Embolic Microspheres Segment by Company
ABK Biomedical
Angio Dynamics
Biocompatibles
Biosphere Medical
BTG Corporate
CeloNova BioSciences
Merit Medical Systems
Mermaid Medical
Next Biomedical
Occlugel
Promedics AG
Teleflex
Tepha
Terumo Corporation
Varian
Nippon Kayaku
Jiangsu Hengrui Medicine
Biodegradable Type Embolic Microspheres Segment by Type
Visualization Type
Radioactive Type
Environmentally Responsive Type
Other
Biodegradable Type Embolic Microspheres Segment by Application
Hospitals And Clinics
Research Institution
Biodegradable Type Embolic Microspheres Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Type Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Type Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Type Embolic Microspheres.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Biodegradable Type Embolic Microspheres market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biodegradable Type Embolic Microspheres industry.
Chapter 3: Detailed analysis of Biodegradable Type Embolic Microspheres market competition landscape. Including Biodegradable Type Embolic Microspheres manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Biodegradable Type Embolic Microspheres by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Biodegradable Type Embolic Microspheres in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Visualization Type
- Radioactive Type
- Environmentally Responsive Type
- Other
Applications
- Hospitals And Clinics
- Research Institution
Companies covered
- ABK Biomedical
- Angio Dynamics
- Biocompatibles
- Biosphere Medical
- BTG Corporate
- CeloNova BioSciences
- Merit Medical Systems
- Mermaid Medical
- Next Biomedical
- Occlugel
- Promedics AG
- Teleflex
- Tepha
- Terumo Corporation
- Varian
- Nippon Kayaku
- Jiangsu Hengrui Medicine
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Biodegradable Type Embolic Microspheres Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Biodegradable Type Embolic Microspheres Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Biodegradable Type Embolic Microspheres Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Biodegradable Type Embolic Microspheres Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Biodegradable Type Embolic Microspheres Market Dynamics
- 2.1 Biodegradable Type Embolic Microspheres Industry Trends
- 2.2 Biodegradable Type Embolic Microspheres Industry Drivers
- 2.3 Biodegradable Type Embolic Microspheres Industry Opportunities and Challenges
- 2.4 Biodegradable Type Embolic Microspheres Industry Restraints
3 Biodegradable Type Embolic Microspheres Market by Manufacturers
- 3.1 Global Biodegradable Type Embolic Microspheres Production Value by Manufacturers (2021-2026)
- 3.2 Global Biodegradable Type Embolic Microspheres Production by Manufacturers (2021-2026)
- 3.3 Global Biodegradable Type Embolic Microspheres Average Price by Manufacturers (2021-2026)
- 3.4 Global Biodegradable Type Embolic Microspheres Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Biodegradable Type Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Biodegradable Type Embolic Microspheres Manufacturers, Product Type & Application
- 3.7 Global Biodegradable Type Embolic Microspheres Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Biodegradable Type Embolic Microspheres Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Biodegradable Type Embolic Microspheres Players Market Share by Production Value in 2025
- 3.8.3 2025 Biodegradable Type Embolic Microspheres Tier 1, Tier 2, and Tier 3
4 Biodegradable Type Embolic Microspheres Market by Type
- 4.1 Biodegradable Type Embolic Microspheres Type Introduction
- 4.1.1 Visualization Type
- 4.1.2 Radioactive Type
- 4.1.3 Environmentally Responsive Type
- 4.1.4 Other
- 4.2 Global Biodegradable Type Embolic Microspheres Production by Type
- 4.2.1 Global Biodegradable Type Embolic Microspheres Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biodegradable Type Embolic Microspheres Production by Type (2021-2032)
- 4.2.3 Global Biodegradable Type Embolic Microspheres Production Market Share by Type (2021-2032)
- 4.3 Global Biodegradable Type Embolic Microspheres Production Value by Type
- 4.3.1 Global Biodegradable Type Embolic Microspheres Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Biodegradable Type Embolic Microspheres Production Value by Type (2021-2032)
- 4.3.3 Global Biodegradable Type Embolic Microspheres Production Value Market Share by Type (2021-2032)
5 Biodegradable Type Embolic Microspheres Market by Application
- 5.1 Biodegradable Type Embolic Microspheres Application Introduction
- 5.1.1 Hospitals And Clinics
- 5.1.2 Research Institution
- 5.2 Global Biodegradable Type Embolic Microspheres Production by Application
- 5.2.1 Global Biodegradable Type Embolic Microspheres Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biodegradable Type Embolic Microspheres Production by Application (2021-2032)
- 5.2.3 Global Biodegradable Type Embolic Microspheres Production Market Share by Application (2021-2032)
- 5.3 Global Biodegradable Type Embolic Microspheres Production Value by Application
- 5.3.1 Global Biodegradable Type Embolic Microspheres Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Biodegradable Type Embolic Microspheres Production Value by Application (2021-2032)
- 5.3.3 Global Biodegradable Type Embolic Microspheres Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 ABK Biomedical
- 6.1.1 ABK Biomedical Company Information
- 6.1.2 ABK Biomedical Business Overview
- 6.1.3 ABK Biomedical Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.1.4 ABK Biomedical Biodegradable Type Embolic Microspheres Product Portfolio
- 6.1.5 ABK Biomedical Recent Developments
- 6.2 Angio Dynamics
- 6.2.1 Angio Dynamics Company Information
- 6.2.2 Angio Dynamics Business Overview
- 6.2.3 Angio Dynamics Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.2.4 Angio Dynamics Biodegradable Type Embolic Microspheres Product Portfolio
- 6.2.5 Angio Dynamics Recent Developments
- 6.3 Biocompatibles
- 6.3.1 Biocompatibles Company Information
- 6.3.2 Biocompatibles Business Overview
- 6.3.3 Biocompatibles Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.3.4 Biocompatibles Biodegradable Type Embolic Microspheres Product Portfolio
- 6.3.5 Biocompatibles Recent Developments
- 6.4 Biosphere Medical
- 6.4.1 Biosphere Medical Company Information
- 6.4.2 Biosphere Medical Business Overview
- 6.4.3 Biosphere Medical Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.4.4 Biosphere Medical Biodegradable Type Embolic Microspheres Product Portfolio
- 6.4.5 Biosphere Medical Recent Developments
- 6.5 BTG Corporate
- 6.5.1 BTG Corporate Company Information
- 6.5.2 BTG Corporate Business Overview
- 6.5.3 BTG Corporate Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.5.4 BTG Corporate Biodegradable Type Embolic Microspheres Product Portfolio
- 6.5.5 BTG Corporate Recent Developments
- 6.6 CeloNova BioSciences
- 6.6.1 CeloNova BioSciences Company Information
- 6.6.2 CeloNova BioSciences Business Overview
- 6.6.3 CeloNova BioSciences Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.6.4 CeloNova BioSciences Biodegradable Type Embolic Microspheres Product Portfolio
- 6.6.5 CeloNova BioSciences Recent Developments
- 6.7 Merit Medical Systems
- 6.7.1 Merit Medical Systems Company Information
- 6.7.2 Merit Medical Systems Business Overview
- 6.7.3 Merit Medical Systems Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.7.4 Merit Medical Systems Biodegradable Type Embolic Microspheres Product Portfolio
- 6.7.5 Merit Medical Systems Recent Developments
- 6.8 Mermaid Medical
- 6.8.1 Mermaid Medical Company Information
- 6.8.2 Mermaid Medical Business Overview
- 6.8.3 Mermaid Medical Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.8.4 Mermaid Medical Biodegradable Type Embolic Microspheres Product Portfolio
- 6.8.5 Mermaid Medical Recent Developments
- 6.9 Next Biomedical
- 6.9.1 Next Biomedical Company Information
- 6.9.2 Next Biomedical Business Overview
- 6.9.3 Next Biomedical Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.9.4 Next Biomedical Biodegradable Type Embolic Microspheres Product Portfolio
- 6.9.5 Next Biomedical Recent Developments
- 6.10 Occlugel
- 6.10.1 Occlugel Company Information
- 6.10.2 Occlugel Business Overview
- 6.10.3 Occlugel Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.10.4 Occlugel Biodegradable Type Embolic Microspheres Product Portfolio
- 6.10.5 Occlugel Recent Developments
- 6.11 Promedics AG
- 6.11.1 Promedics AG Company Information
- 6.11.2 Promedics AG Business Overview
- 6.11.3 Promedics AG Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.11.4 Promedics AG Biodegradable Type Embolic Microspheres Product Portfolio
- 6.11.5 Promedics AG Recent Developments
- 6.12 Teleflex
- 6.12.1 Teleflex Company Information
- 6.12.2 Teleflex Business Overview
- 6.12.3 Teleflex Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.12.4 Teleflex Biodegradable Type Embolic Microspheres Product Portfolio
- 6.12.5 Teleflex Recent Developments
- 6.13 Tepha
- 6.13.1 Tepha Company Information
- 6.13.2 Tepha Business Overview
- 6.13.3 Tepha Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.13.4 Tepha Biodegradable Type Embolic Microspheres Product Portfolio
- 6.13.5 Tepha Recent Developments
- 6.14 Terumo Corporation
- 6.14.1 Terumo Corporation Company Information
- 6.14.2 Terumo Corporation Business Overview
- 6.14.3 Terumo Corporation Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.14.4 Terumo Corporation Biodegradable Type Embolic Microspheres Product Portfolio
- 6.14.5 Terumo Corporation Recent Developments
- 6.15 Varian
- 6.15.1 Varian Company Information
- 6.15.2 Varian Business Overview
- 6.15.3 Varian Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.15.4 Varian Biodegradable Type Embolic Microspheres Product Portfolio
- 6.15.5 Varian Recent Developments
- 6.16 Nippon Kayaku
- 6.16.1 Nippon Kayaku Company Information
- 6.16.2 Nippon Kayaku Business Overview
- 6.16.3 Nippon Kayaku Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.16.4 Nippon Kayaku Biodegradable Type Embolic Microspheres Product Portfolio
- 6.16.5 Nippon Kayaku Recent Developments
- 6.17 Jiangsu Hengrui Medicine
- 6.17.1 Jiangsu Hengrui Medicine Company Information
- 6.17.2 Jiangsu Hengrui Medicine Business Overview
- 6.17.3 Jiangsu Hengrui Medicine Biodegradable Type Embolic Microspheres Production, Value and Gross Margin (2021-2026)
- 6.17.4 Jiangsu Hengrui Medicine Biodegradable Type Embolic Microspheres Product Portfolio
- 6.17.5 Jiangsu Hengrui Medicine Recent Developments
7 Global Biodegradable Type Embolic Microspheres Production by Region
- 7.1 Global Biodegradable Type Embolic Microspheres Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Biodegradable Type Embolic Microspheres Production by Region (2021-2032)
- 7.2.1 Global Biodegradable Type Embolic Microspheres Production by Region (2021-2026)
- 7.2.2 Global Biodegradable Type Embolic Microspheres Production Forecast by Region (2027-2032)
- 7.3 Global Biodegradable Type Embolic Microspheres Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Biodegradable Type Embolic Microspheres Production Value by Region (2021-2032)
- 7.4.1 Global Biodegradable Type Embolic Microspheres Production Value by Region (2021-2026)
- 7.4.2 Global Biodegradable Type Embolic Microspheres Production Value by Region (2027-2032)
- 7.5 Global Biodegradable Type Embolic Microspheres Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Biodegradable Type Embolic Microspheres Production Value (2021-2032)
- 7.6.2 Europe Biodegradable Type Embolic Microspheres Production Value (2021-2032)
- 7.6.3 Asia-Pacific Biodegradable Type Embolic Microspheres Production Value (2021-2032)
- 7.6.4 South America Biodegradable Type Embolic Microspheres Production Value (2021-2032)
- 7.6.5 Middle East & Africa Biodegradable Type Embolic Microspheres Production Value (2021-2032)
8 Global Biodegradable Type Embolic Microspheres Consumption by Region
- 8.1 Global Biodegradable Type Embolic Microspheres Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Biodegradable Type Embolic Microspheres Consumption by Region (2021-2032)
- 8.2.1 Global Biodegradable Type Embolic Microspheres Consumption by Region (2021-2026)
- 8.2.2 Global Biodegradable Type Embolic Microspheres Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Biodegradable Type Embolic Microspheres Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Biodegradable Type Embolic Microspheres Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Biodegradable Type Embolic Microspheres Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Biodegradable Type Embolic Microspheres Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Biodegradable Type Embolic Microspheres Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Biodegradable Type Embolic Microspheres Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Biodegradable Type Embolic Microspheres Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Biodegradable Type Embolic Microspheres Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Biodegradable Type Embolic Microspheres Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Biodegradable Type Embolic Microspheres Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Biodegradable Type Embolic Microspheres Value Chain Analysis
- 9.1.1 Biodegradable Type Embolic Microspheres Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Biodegradable Type Embolic Microspheres Production Mode & Process
- 9.2 Biodegradable Type Embolic Microspheres Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biodegradable Type Embolic Microspheres Distributors
- 9.2.3 Biodegradable Type Embolic Microspheres Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst